background image

Paid Clinical Trials Denver

Discover 1,564 paid clinical trials in Denver. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Recruiting
PHASE1
PHASE2

Sponsor:

Nuvalent Inc.

Location:

Denver, Saint Louis, Orange, Houstonshow 19 more

Code:

NCT05384626

Conditions

Locally Advanced Solid Tumor

Metastatic Solid Tumor

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

NVL-655

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Littleton, Oklahoma City, Mesa, Valenciashow 10 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting
PHASE3

Sponsor:

GB002, Inc.

Location:

Aurora, Albuquerque, Murray, Omahashow 47 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

Recruiting
PHASE3

Sponsor:

VistaGen Therapeutics, Inc.

Location:

Denver, Albuquerque, Las Vegas, Austinshow 8 more

Code:

NCT06615557

Conditions

Social Anxiety Disorder (SAD)

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Fasedienol Nasal Spray

Placebo Nasal Spray

Rare and Atypical Diabetes Network

Recruiting

Sponsor:

University of South Florida

Location:

Aurora, Saint Louis, Houston, Chicagoshow 9 more

Code:

NCT05544266

Conditions

Diabetes Mellitus

Diabetes Mellitus Progression

Glucose Intolerance

Glucose Metabolism Disorders

Metabolic Disease

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
PHASE2
PHASE3

Sponsor:

Biohaven Therapeutics Ltd.

Location:

Aurora, Murray, Lincoln, El Pasoshow 27 more

Code:

NCT06309966

Conditions

Focal Epilepsy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BHV-7000

Placebo

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Denver, Aurora, Rapid City, Albuquerqueshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting
PHASE1
PHASE2

Sponsor:

Amgen

Location:

Aurora, Irving, Dallas, Tylershow 8 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab

A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Wheat Ridge, Englewood, West Jordan, Sioux Cityshow 64 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

A Study of NX-1607 in Adults With Advanced Malignancies

Recruiting
PHASE1

Sponsor:

Nurix Therapeutics, Inc.

Location:

Aurora, Oklahoma City, Duarte, Los Angelesshow 7 more

Code:

NCT05107674

Conditions

Ovarian Cancer, Epithelial

Gastric Cancer

GastroEsophageal Junction (GEJ) Cancer

Head and Neck Squamous Cell Carcinoma

Metastatic or Unresectable Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NX-1607

Paclitaxel

Denver is a pivotal hub for clinical trials, thanks to its sturdy healthcare network and renowned medical research institutions. Prominent centers such as the University of Colorado Anschutz Medical Campus, Denver Health, and Children’s Hospital Colorado are at the forefront of groundbreaking studies focusing on areas including cancer research, neurological disorders, and chronic diseases.

Denver's strong emphasis on collaboration among healthcare providers, researchers, and community organizations fosters an environment conducive to medical advancements. By participating in clinical trials in Denver, individuals not only gain access to cutting-edge therapies but also contribute significantly to the progress of medical science.

Why choose Denver for clinical trials?

Common conditions studied in Denver

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Denver